United-Guardian (NASDAQ: UG) — Company Overview, News & Financial Data
United-Guardian is a diversified company focused on developing pharmaceuticals and healthcare products with high standards.
United-Guardian
United-Guardian (NASDAQ:UG) is a diversified company engaged in the research, development, and manufacture of a wide range of innovative products, including pharmaceuticals, personal care products, medical, and health care products. They focus on creating high-quality, reliable products that cater to consumer and professional healthcare needs. With a strong commitment to research and innovation, United-Guardian aims to expand its product offerings and explore new markets to meet the evolving demands of the global marketplace. Their objective is to enhance shareholder value through strategic growth initiatives, maintaining a strong focus on sustainability and ethical business practices while ensuring the highest product standards and customer satisfaction.
Snapshot
Operations
Products and/or services of United-Guardian
- Lubrajel, a range of hydrophilic gel formulations used in personal care and pharmaceutical products.
- Renacidin, a pharmaceutical product for dissolving certain types of urinary bladder stones.
- Lubrasil, a line of water-soluble lubricating ingredient for personal care products.
- Klensoft, a surfactant and conditioning agent used in cosmetic and personal care formulations.
- Carmasol, a skin conditioner and protectant used in cosmetics and personal care products.
United-Guardian executive team
- Donna VigilantePresident & Director
- Andrea J. YoungCFO, Treasurer, Controller, Secretary & Human Resources Manager
- Denise CostriniMarketing Director
Latest news about United-Guardian
Dividend history
Dividends per share paid by United-Guardian, by financial year.
| Financial year | Interim | Final | Special | Total |
|---|---|---|---|---|
| FY2026(to date) | — | — | — | $0.5500 |
| FY2025 | — | — | — | $0.6000 |
| FY2024 | — | — | — | $0.6000 |
| FY2023 | — | — | — | $0.1000 |
| FY2022 | — | — | — | $0.6800 |
Key financials
Reported results for United-Guardian, in USD.
- Market cap
- 32.5M
- Revenue (TTM)
- 11.2M
- P/E ratio
- 13.1
- EPS (diluted, TTM)
- 0.5
- Dividend yield
- 6.0%
- Profit margin
- 22.0%
| Fiscal year end | Revenue | Operating income | Net income |
|---|---|---|---|
| 10.5M | 2.2M | 2.1M | |
| 12.2M | 3.6M | 3.3M | |
| 10.9M | 2.9M | 2.6M | |
| 12.7M | 4M | 2.6M |